These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10724642)

  • 1. Intrapulmonary distribution of deposited particles.
    Brand P; Häussinger K; Meyer T; Scheuch G; Schulz H; Selzer T; Heyder J
    J Aerosol Med; 1999; 12(4):275-84. PubMed ID: 10724642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting aerosolized drugs to the conducting airways using very large particles and extremely slow inhalations.
    Zeman KL; Wu J; Bennett WD
    J Aerosol Med Pulm Drug Deliv; 2010 Dec; 23(6):363-9. PubMed ID: 20863250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Study on the Size Distributions, Respiratory Deposition, and Transport of Particles Generated from Commonly Used Medical Nebulizers.
    Wang Y; Li J; Leavey A; O'Neil C; Babcock HM; Biswas P
    J Aerosol Med Pulm Drug Deliv; 2017 Apr; 30(2):132-140. PubMed ID: 27977321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficient computational fluid-particle dynamics method to predict deposition in a simplified approximation of the deep lung.
    Koullapis PG; Hofemeier P; Sznitman J; Kassinos SC
    Eur J Pharm Sci; 2018 Feb; 113():132-144. PubMed ID: 28917963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bi-directional nasal delivery of aerosols can prevent lung deposition.
    Djupesland PG; Skretting A; Winderen M; Holand T
    J Aerosol Med; 2004; 17(3):249-59. PubMed ID: 15625817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches to enhance pulmonary delivery of proteins and peptides.
    Scheuch G; Siekmeier R
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):615-25. PubMed ID: 18204175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting the deposition of inhaled porous drug particles.
    Musante CJ; Schroeter JD; Rosati JA; Crowder TM; Hickey AJ; Martonen TB
    J Pharm Sci; 2002 Jul; 91(7):1590-600. PubMed ID: 12115821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particle size-dependent total mass deposition in lungs determines inhalation toxicity of cadmium chloride aerosols in rats. Application of a multiple path dosimetry model.
    Cassee FR; Muijser H; Duistermaat E; Freijer JJ; Geerse KB; Marijnissen JC; Arts JH
    Arch Toxicol; 2002 Jun; 76(5-6):277-86. PubMed ID: 12107645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CFD simulation of aerosol delivery to a human lung via surface acoustic wave nebulization.
    Yousefi M; Pourmehran O; Gorji-Bandpy M; Inthavong K; Yeo L; Tu J
    Biomech Model Mechanobiol; 2017 Dec; 16(6):2035-2050. PubMed ID: 28735415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational investigation of flow characteristics and particle deposition patterns in a realistic human airway model under different breathing conditions.
    Liu H; Ma S; Hu T; Ma D
    Respir Physiol Neurobiol; 2023 Aug; 314():104085. PubMed ID: 37276915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of drugs to humans via inhalation.
    Gonda I
    J Aerosol Med; 2006; 19(1):47-53. PubMed ID: 16551214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total deposition of therapeutic particles during spontaneous and controlled inhalations.
    Brand P; Friemel I; Meyer T; Schulz H; Heyder J; Häubetainger K
    J Pharm Sci; 2000 Jun; 89(6):724-31. PubMed ID: 10824130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of realistic airflow rate on aerosol generation by nebulizers.
    Vecellio L; Kippax P; Rouquette S; Diot P
    Int J Pharm; 2009 Apr; 371(1-2):99-105. PubMed ID: 19150494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miniature inhalation therapy platform using surface acoustic wave microfluidic atomization.
    Qi A; Friend JR; Yeo LY; Morton DA; McIntosh MP; Spiccia L
    Lab Chip; 2009 Aug; 9(15):2184-93. PubMed ID: 19606295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmenting regional and targeted delivery in the pulmonary acinus using magnetic particles.
    Ostrovski Y; Hofemeier P; Sznitman J
    Int J Nanomedicine; 2016; 11():3385-95. PubMed ID: 27547034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An approach to deposition and clearance measurements in human airways.
    Scheuch G; Stahlhofen W; Heyder J
    J Aerosol Med; 1996; 9(1):35-41. PubMed ID: 10160207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of aerosol particles in the human nose.
    Heyder J; Rudolf G
    Inhaled Part; 1975 Sep; 4 Pt 1():107-26. PubMed ID: 1236151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum peripheral drug deposition in patients with cystic fibrosis.
    Brand P; Meyer T; Häussermann S; Schulte M; Scheuch G; Bernhard T; Sommerauer B; Weber N; Griese M
    J Aerosol Med; 2005; 18(1):45-54. PubMed ID: 15741773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of particle size on slow particle clearance from the bronchial tree.
    Smith JR; Bailey MR; Etherington G; Shutt AL; Youngman MJ
    Exp Lung Res; 2008 Aug; 34(6):287-312. PubMed ID: 18600497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.